Trial Profile

Pilot Phase 2 Study of Intratumoral G100 in Patients With Cutaneous T Cell Lymphoma

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 19 Dec 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Glycopyranosyl lipid adjuvant (Primary) ; Glycopyranosyl lipid adjuvant (Primary) ; Nitrogen mustard compounds
Indications Cutaneous T-cell lymphoma
Focus Therapeutic Use

Most Recent Events

16 Dec 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
17 May 2019 Planned initiation date changed from 1 Feb 2019 to 1 Jun 2019.
04 Jan 2019 Planned initiation date changed from 1 Nov 2018 to 1 Feb 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com